NAC Dosage Guide: Protocols, Calculator & Safety

NAC stacks coherently with other glutathione-pathway and antioxidant-system interventions, with a few combinations being particularly well-motivated and a few being redundant or counterproductive.

Well-motivated combinations:

• Glutathione (oral liposomal, intranasal, IV): NAC-plus-GSH is additive rather than redundant — NAC provides the cysteine substrate for endogenous GSH synthesis while exogenous GSH provides direct repletion of the circulating/tissue GSH pool. The combination is commonly used in acute GSH-depletion contexts (post-exercise oxidative stress, heavy toxicant exposure, post-surgical recovery) and in chronic contexts (aging, neurodegenerative risk, environmental illness).
• Alpha-lipoic acid (ALA): ALA recycles oxidized glutathione (GSSG) back to GSH and is itself a thiol antioxidant operating in both aqueous and lipid compartments. ALA-plus-NAC is a classic mitochondrial antioxidant combination, with rationale for combined use in diabetic neuropathy, metabolic syndrome, and cognitive support protocols.
• Selenium: Selenium is the cofactor for glutathione peroxidases (GPx). Without adequate selenium, GSH cannot efficiently neutralize hydrogen peroxide and lipid peroxides. For populations with selenium deficiency (soil-dependent geographic variation is significant), selenium supplementation at 100-200 mcg/day enables NAC-restored GSH to do its antioxidant work.
• Glycine: Glycine is the third amino acid in GSH (γ-Glu-Cys-Gly) and can also be rate-limiting in older adults whose glycine intake is below optimal. The GlyNAC (glycine + N-acetylcysteine) protocol developed by Sekhar and colleagues at Baylor has shown improvements in oxidative stress markers, mitochondrial function, inflammation, insulin resistance, and physical performance in older adults (Kumar et al. 2021, PMID 33877370; Kumar et al. 2023).
• CoQ10: Mitochondrial support combination — NAC supports cytosolic and mitochondrial GSH while CoQ10 supports electron transport chain function. Common combination for cardiac support, chemotherapy protection, statin-associated myopathy, and general mitochondrial health.
• Vitamin C and E: Vitamin C recycles oxidized vitamin E, and GSH (from NAC) recycles oxidized vitamin C. The three-way antioxidant cycle is foundational — NAC without adequate vitamin C and E is operating with partial infrastructure.
• Metformin: Particularly relevant for PCOS and metabolic syndrome protocols where NAC contributes insulin sensitization and antioxidant protection while metformin addresses gluconeogenesis and glycemic control.
• Thymosin Alpha-1: For immune-supportive protocols, particularly in post-viral recovery or chronic infection contexts, NAC's immunomodulatory and mucolytic effects complement thymalpha-1's T-cell enhancement.

Potentially redundant or suboptimal combinations:

• NAC + SAMe: Both use methionine cycle intermediates; supplementing both at high doses may not provide additive benefit and can shift methylation balance. Generally better to address methylation (SAMe, methylfolate, methyl B12) and thiol status (NAC) as separate considerations rather than stacking both at high doses.
• NAC + extremely high-dose vitamin E or beta-carotene: High-dose antioxidant vitamins have shown mixed outcomes in cardiovascular and cancer prevention trials (some evidence of harm), and adding NAC to high-dose antioxidant cocktails may not be advisable outside of specific clinical indications.
• NAC + reduced glutathione oral: Oral reduced glutathione has poor bioavailability and the NAC-plus-oral-GSH combination is largely redundant with either alone. Liposomal GSH or IV GSH is a more coherent addition to NAC.

Athletic and exercise combinations. NAC's effects on exercise are context-dependent and somewhat controversial. Acute NAC before exercise may reduce muscle fatigue via maintained muscle GSH, but high doses may blunt exercise-induced redox signaling that drives adaptation (analogous to the concerns about high-dose vitamin C and E for trained athletes). The consensus is emerging that NAC is fine for general health and specific indications but athletes pursuing training adaptation may want to avoid high-dose NAC around training sessions. Post-exercise NAC is less concerning than pre-exercise NAC from the adaptation-signaling perspective.

Psychiatric combinations. NAC is commonly combined with established psychiatric medications (SSRIs, mood stabilizers, antipsychotics) as an adjunct rather than a replacement. There are no major pharmacokinetic interactions and the combinations are generally well-tolerated. For bipolar depression, the Berk 2008 protocol used NAC as an add-on to standard therapy. For OCD and trichotillomania, NAC is similarly an adjunct to SSRIs and/or behavioral therapy. Discuss with prescribing clinician before combining.

Contraindicated combinations. None absolutely contraindicated. Caution with organic nitrates (potentiated vasodilation) and with high-dose anticoagulants (NAC has modest platelet effects at high doses). Timing away from activated charcoal in the emergency department context (both-same-time reduces NAC absorption).

Dosing ranges by indication:

• General supplement / beginner: 600 mg/day
• COPD / mucolytic: 600-1200 mg/day
• Psychiatric adjunct (Berk protocol): 2000 mg/day (1000 mg twice daily)
• Male infertility: 600 mg/day
• PCOS / insulin sensitization: 1200-1800 mg/day
• Research / advanced protocols: up to 3600 mg/day under supervision
• GlyNAC protocol: weight-based, ~100 mg/kg/day (6-9 g/day in most adults) with matched glycine
• Acetaminophen overdose (IV): 150 + 50 + 100 mg/kg over 20.25 hours (Prescott protocol)
• Acetaminophen overdose (oral): 140 mg/kg loading + 70 mg/kg every 4 hours × 17 doses (Smilkstein protocol)

Formulation selection:

• Capsules (500-600 mg): Most common supplement format. Convenient, portable, relatively stable. Look for third-party tested products; NAC oxidizes over time and cheap products may contain substantial cystine (oxidized) rather than active NAC.
• Effervescent tablets (600 mg, e.g., ACC/Fluimucil): OTC in Europe and some Asian markets. Fast-dissolving in water, better tolerability for some users, slight taste issue from the sulfur.
• Sustained-release formulations: Available but less commonly used for supplement dosing.
• Powder (bulk): Available from supplement vendors. Cost-effective for high-dose protocols but must be consumed quickly after mixing to avoid oxidation.
• IV (Acetadote, Parvolex): Prescription-only, hospital use.
• Nebulized (Mucomyst 10% or 20%): Prescription-only, respiratory therapy use.
• Intranasal (compounded): Specialty pharmacies; used for some research-context brain-delivery protocols.

Timing:

• Morning and midday preferred over evening (some users report sleep disruption or vivid dreams with evening dosing).
• With food to minimize GI side effects.
• For psychiatric protocols, consistent daily dosing is more important than specific timing.
• Avoid dosing simultaneously with activated charcoal (they bind each other).
• For the acetaminophen overdose protocols, timing is critical and dictated by the hospital protocol.

Storage:

• Keep in original container with desiccant
• Room temperature, away from direct light
• Do not use expired product — NAC oxidizes over time to cystine (dimer), reducing potency
• Effervescent tablets should be kept dry until use

Cost considerations:

• Generic oral NAC 600 mg: typically $0.05-$0.20 per capsule for high-quality product; bulk powder dramatically cheaper
• Effervescent ACC/Fluimucil: $0.30-$0.80 per tablet depending on market
• IV Acetadote: hospital formulary cost; insurance-covered in acute poisoning context

Bioavailability optimization:

• Oral NAC has 4-10% bioavailability as intact NAC but significantly raises plasma cysteine (the pharmacologically active species for GSH synthesis).
• Liposomal NAC products claim improved bioavailability but the evidence is modest; standard oral NAC at correct doses is generally adequate.
• IV bypasses first-pass metabolism but is only indicated in specific clinical contexts.